NSC 654261
Latest Information Update: 14 Feb 2000
At a glance
- Originator Nonindustrial source
- Developer Nonindustrial source; Southern Research Institute
- Class Antineoplastics
- Mechanism of Action Mitosis inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 14 Feb 2000 No-Development-Reported for Cancer in USA (Unknown route)
- 20 Feb 1997 New profile
- 20 Feb 1997 Preclinical development for Cancer in USA (Unknown route)